Literature DB >> 21051733

Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.

Isabelle Golbaz1, Christian Ahlers, Geraldine Stock, Christopher Schütze, Sabine Schriefl, Ferdinand Schlanitz, Christian Simader, Christian Prünte, Ursula Margarethe Schmidt-Erfurth.   

Abstract

PURPOSE: To analyze the functional and morphologic effects of different ranibizumab treatment regimens on retinal and subretinal as well as sub-RPE compartments in neovascular age-related macular degeneration (nAMD) using spectral-domain optical coherence tomography (SD-OCT) and manual segmentation software.
METHODS: Twenty-seven eyes of 27 patients with nAMD were examined over a 12-month period. Two treatment arms received either monthly or quarterly administered intravitreal ranibizumab. Intraretinal, subretinal, and sub-RPE volume equivalents were delineated using manual segmentation software over a defined series of B-scans obtained by SD-OCT. The mean area in pixels was calculated for each compartment at each time interval.
RESULTS: SD-OCT and manual segmentation allowed for exact identification of intraretinal, subretinal and sub-RPE compartments and their responses to different treatment regimens. The loading dose demonstrated a corresponding treatment effect on all anatomic parameters. In contrast to the sub-RPE compartment, intraretinal fluid accumulation and subretinal fluid accumulation (SRFA) demonstrated an immediate response to ranibizumab therapy. The overall plasticity of the morphologic response declined over time. In general, SRFA demonstrated greater sensitivity for therapeutic effects and was more frequently associated with recurrent disease.
CONCLUSIONS: An exact quantification of fluid in different anatomic compartments based on SD-OCT imaging, using appropriate segmentation software systems, may be useful to determine optimal treatment and retreatment parameters and explains the lack of correlation of best-corrected visual acuity and conventional OCT values.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21051733     DOI: 10.1167/iovs.09-5018

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration.

Authors:  Akio Oishi; Masataka Shimozono; Michiko Mandai; Masayuki Hata; Akihiro Nishida; Yasuo Kurimoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-12       Impact factor: 3.117

2.  Deep-learning based, automated segmentation of macular edema in optical coherence tomography.

Authors:  Cecilia S Lee; Ariel J Tyring; Nicolaas P Deruyter; Yue Wu; Ariel Rokem; Aaron Y Lee
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

3.  Dual-stage deep learning framework for pigment epithelium detachment segmentation in polypoidal choroidal vasculopathy.

Authors:  Yupeng Xu; Ke Yan; Jinman Kim; Xiuying Wang; Changyang Li; Li Su; Suqin Yu; Xun Xu; Dagan David Feng
Journal:  Biomed Opt Express       Date:  2017-08-10       Impact factor: 3.732

4.  Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters.

Authors:  Jae Hyung Lee; Won Ki Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-03       Impact factor: 3.117

5.  Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?

Authors:  Focke Ziemssen; Bianka Sobolewska
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

6.  Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Authors:  Ugo Introini; Ana Torres Gimeno; Fabrizio Scotti; Marco Setaccioli; Silvia Giatsidis; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

7.  Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

Authors:  Meidong Zhu; Jamie K Chew; Geoffrey K Broadhead; Kehui Luo; Nichole Joachim; Thomas Hong; Adil Syed; Andrew A Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-10       Impact factor: 3.117

8.  Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Authors:  Francisco A Folgar; Glenn J Jaffe; Gui-Shuang Ying; Maureen G Maguire; Cynthia A Toth
Journal:  Ophthalmology       Date:  2014-05-15       Impact factor: 12.079

9.  Response to anti-VEGF therapy in patients with subretinal fluid and pigment epithelial detachment on spectral-domain optical coherence tomography.

Authors:  Lebriz Ersoy; Tina Ristau; Bernd Kirchhof; Sandra Liakopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-26       Impact factor: 3.117

10.  Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Florian M Heussen; Yanling Ouyang; Nils Mokwa; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda; Praveen J Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.